Safety, tolerability and pharmacokinetic endpoints successfully met Follow-on clinical trials to be initiated in 2023 Mission Therapeutics ("Mission"), a drug discovery and development
Merck announced the winner of the 2022 Future Insight Prize in the category of “Energy”. The € 1 million prize was awarded at the “Curious2022 – Future Insight” scientific conference in Darmstadt, .
Mission Therapeutics ("Mission"), a drug discovery and development company focused on protein homeostasis by selectively inhibiting deubiquitylating enzymes (DUBs), today announced it has been granted
Collaborative team to progress novel USP30 DUB inhibitors to develop potential therapies for Parkinson's disease Mission Therapeutics ("Mission"), a drug discovery and development company focused
Mission Therapeutics to Participate in the Solebury Trout Fall Private Company Showcase 2021 financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.